Genome-wide association study identifies novel genetic loci affecting REM and NREM sleep in the UK Biobank cohort, suggesting health implications.
Sleep is essential for health and regulated by genetic and environmental factors. We performed genome-wide association studies of device-measured sleep duration, efficiency, and REM/NREM phases in 80,013 UK Biobank participants using accelerometer measurements separately validated against polysomnography. We identified 20 autosomal loci, 12 of which were novel, and report the first genome-wide significant signals for REM and NREM sleep duration. MEIS1 showed strong opposing effects on REM and NREM durations and is intolerant to loss-of-function mutations, suggesting a regulatory role. Functional enrichment implicated chromatin remodelling, lipid metabolism, and metal ion homeostasis; tissue enrichment highlighted regions including the hypothalamus and frontal cortex. Sex-stratified analyses identified distinct loci: FOXP2 and NRXN3 in females and LRP1B, NPBWR2, and PABPC4 in males. Mendelian randomization supported associations between shorter sleep duration and higher cardiometabolic risk. Our findings highlight novel sex- and phase-specific regulators of human sleep architecture, offering biological insights and potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Portas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: